Research published in the Bangladesh Medical Research Council Bulletin (2009; 35(2):63–68) examined the effects of omega-3 fatty acid supplementation in patients with rheumatoid arthritis.
In this study, participants were divided into two groups. Both groups received indomethacin, a commonly prescribed nonsteroidal anti-inflammatory drug (NSAID). One group received indomethacin alone, while the second group received indomethacin along with 3 grams per day of omega-3 fatty acids.
When outcomes were compared, the group receiving omega-3 supplementation in addition to medication showed:
-
Improved physical function
-
Reduced pain
-
Greater grip strength
These improvements were not observed to the same degree in the group receiving medication alone.
Context
This study suggests that omega-3 fatty acids may influence inflammatory and functional outcomes in individuals with rheumatoid arthritis when used alongside conventional therapy. Rather than replacing medication, omega-3 supplementation in this research appeared to enhance clinical measures related to pain and physical performance.
As with many nutritional intervention studies, individual responses varied, and the findings do not establish universal benefit. However, the results contribute to a broader body of research exploring how dietary fats may affect inflammatory joint conditions.
